Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Lamb Weston | LW | Oct 11, 2024 | 71.35 | +0.54 |
Lancaster Colony | LANC | Oct 11, 2024 | 180.28 | +1.16 |
Landbridge Company | LB | Oct 11, 2024 | 49.02 | +4.32 |
Landmark Bancorp | LARK | Oct 11, 2024 | 20.49 | +1.19 |
Lands End | LE | Oct 11, 2024 | 17.06 | +6.16 |
Landsea Homes | LSEA | Oct 11, 2024 | 11.13 | +1.27 |
Landstar System | LSTR | Oct 11, 2024 | 187.78 | +3.03 |
Lantern Pharma | LTRN | Oct 11, 2024 | 3.48 | +2.65 |
Lantheus | LNTH | Oct 11, 2024 | 112.19 | +3.72 |
Lantronix | LTRX | Oct 11, 2024 | 4.00 | +5.67 |
Lanvin Group | LANV | Oct 11, 2024 | 1.69 | 0.00 |
Lanzatech Global | LNZA | Oct 11, 2024 | 2.10 | +9.95 |
Largecap Core Alphadex First Trust | FEX | Oct 11, 2024 | 105.44 | +1.15 |
Largecap Dividend Wisdomtree | DLN | Oct 11, 2024 | 79.53 | +0.91 |
Largecap ETF Vanguard | VV | Oct 11, 2024 | 266.00 | +0.56 |
Largecap Growth Opp Alphadex First Trust | FTC | Oct 11, 2024 | 134.75 | +1.51 |
Largecap Value Opp Alphadex First Trust | FTA | Oct 11, 2024 | 79.50 | +1.15 |
Largo | LGO | Oct 11, 2024 | 2.09 | +7.18 |
Larimar Therapeutics | LRMR | Oct 11, 2024 | 6.99 | +3.10 |
Las Vegas Sands | LVS | Oct 11, 2024 | 52.87 | +1.65 |
Laser Photonics | LASE | Oct 11, 2024 | 8.53 | +2.77 |
Latham Group | SWIM | Oct 11, 2024 | 6.95 | +1.61 |
Latin America Alphadex First Trust | FLN | Oct 11, 2024 | 17.52 | -0.17 |
Lattice Semiconductor | LSCC | Oct 11, 2024 | 52.07 | +1.48 |
Launch One Acquisition | LPAA | Oct 11, 2024 | 9.96 | 0.00 |
Launch One Acquisition | LPAAU | Oct 11, 2024 | 10.00 | 0.00 |
Laureate Education | LAUR | Oct 11, 2024 | 15.36 | -1.54 |
LAVA Therapeutics | LVTX | Oct 11, 2024 | 1.65 | +3.13 |
Lavoro | LVRO | Oct 11, 2024 | 4.40 | +15.49 |
Lazard A | LAZ | Oct 11, 2024 | 52.70 | +5.38 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.